|
|
Article: Thomson Physicians World: New Study Indicates Pioglitazone HCl/Metformin Combination Therapy Enhances Glycemic Control in Patients With Type 2 Diabetes.
- Article from:
- Business Wire
- Article date:
- November 7, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Medical Writers
SECAUCUS, N.J.--(BUSINESS WIRE)--Nov. 7, 2002
Significant Improvement Seen in a Leading Indicator
of Cardiovascular Disease
Diabetes patients taking the insulin sensitizer pioglitazone HCl in combination with metformin experienced significantly greater improvement in triglyceride levels than patients taking rosiglitazone maleate and metformin, according to the results of a new multi-center, retrospective study being presented this week at the 193rd Meeting of the Society for Endocrinology in London.
Patients with diabetes have an increased risk of morbidity and mortality due to heart disease ...